California will cap insulin co-pays at $35 and launch CalRx state-branded insulin in 2026 under new legislation signed by ...

Philadelphia has filed a lawsuit against several major drug manufacturers and pharmacy benefit managers, accusing them of ...

Two counties in the Charlotte area have filed lawsuits in the last few weeks over the price of insulin. Gaston County and Lincoln County join hundreds of similar lawsuits against drug makers, ...

About 14% of adults in Philadelphia have diabetes, one of the highest rates in the country, the city said, and Black and ...

Philadelphia sues Pharmacy Benefit Managers and insulin manufacturers for allegedly colluding to inflate insulin prices, ...

California State Sen. Scott Wiener, D-San Francisco, recently introduced legislation that would cap cost-sharing for insulin at $35 a month, regardless of whether a patient has public or private ...

Former President Trump attempted to take credit for insulin pricing in a Saturday post on Truth Social. “Low INSULIN PRICING was gotten for millions of Americans by me, and the Trump Administration, ...

The commonwealth claims that pharmacy benefit managers and drug manufacturers are in cahoots to inflate insulin prices for ...

Recent debates over skyrocketing drug prices are directly impacting diabetes patients, but it’s an extremely complex situation said Aaron Kowalski, chief mission officer at the Juvenile Diabetes ...